Detalhe da pesquisa
1.
Stimuli-responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy.
Immunol Rev
; 321(1): 181-198, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37403660
2.
Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma.
N Engl J Med
; 389(19): 1778-1789, 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870949
3.
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
N Engl J Med
; 386(12): 1132-1142, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35179323
4.
Whole-exome sequencing reveals a comprehensive germline mutation landscape and identifies twelve novel predisposition genes in Chinese prostate cancer patients.
PLoS Genet
; 18(9): e1010373, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36095024
5.
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study.
Lancet Oncol
; 25(1): 29-45, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38101433
6.
Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma detection: a double-blinded, multicenter, prospective trial.
Mol Cancer
; 23(1): 57, 2024 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38504268
7.
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial.
Lancet
; 401(10379): 821-832, 2023 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36774933
8.
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.
N Engl J Med
; 384(22): 2102-2114, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077643
9.
Deciphering the prognostic features of bladder cancer through gemcitabine resistance and immune-related gene analysis and identifying potential small molecular drug PIK-75.
Cancer Cell Int
; 24(1): 125, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38570787
10.
Prostate-specific antigen (PSA) decline with apalutamide therapy is associated with longer survival and improved outcomes in individuals with metastatic prostate cancer: a plain language summary of the TITAN study.
Future Oncol
; 20(10): 563-578, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38126311
11.
Single-cell RNA-seq analysis decodes the kidney microenvironment induced by polystyrene microplastics in mice receiving a high-fat diet.
J Nanobiotechnology
; 22(1): 13, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38167034
12.
Letter to the Editor: clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma.
Mol Cancer
; 22(1): 25, 2023 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36739413
13.
The function and mechanisms of action of circular RNAs in Urologic Cancer.
Mol Cancer
; 22(1): 61, 2023 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36966306
14.
Special issue "The advance of solid tumor research in China": Presurgical therapy in the management of local retroperitoneal recurrence of renal cell carcinoma after radical nephrectomy.
Int J Cancer
; 152(1): 24-30, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35712762
15.
Special issue "The advance of solid tumor research in China": Multi-omics analysis based on 1311 clear cell renal cell carcinoma samples identifies a glycolysis signature associated with prognosis and treatment response.
Int J Cancer
; 152(1): 66-78, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579992
16.
Proxalutamide in metastatic castration-resistant prostate cancer: Primary analysis of a multicenter, randomized, open-label, phase 2 trial.
Int J Cancer
; 153(4): 792-802, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919366
17.
Prevalence of mismatch repair genes mutations and clinical activity of PD-1 therapy in Chinese prostate cancer patients.
Cancer Immunol Immunother
; 72(6): 1541-1551, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36522531
18.
Concomitant vs Staged Therapeutic Inguinal Lymphadenectomy in Clinically Node Positive Penile Squamous Cell Carcinoma: Does It Make a Difference?
J Urol
; 209(3): 557-564, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652397
19.
Prostate Health Index Density Outperforms Prostate-specific Antigen Density in the Diagnosis of Clinically Significant Prostate Cancer in Equivocal Magnetic Resonance Imaging of the Prostate: A Multicenter Evaluation.
J Urol
; 210(1): 88-98, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036248
20.
Heterogeneity of [68Ga]Ga-PSMA-11 PET/CT in metastatic castration-resistant prostate cancer: genomic characteristics and association with abiraterone response.
Eur J Nucl Med Mol Imaging
; 50(6): 1822-1832, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719427